Transcriptomics of SGLT2-positive early proximal tubule segments in mice: response to type 1 diabetes, SGLT1/2 inhibition or GLP1 receptor agonism
RNA-seq (gene expression) · mouse · 54 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Samples
- 54 samples
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Transcriptomics of SGLT2-positive early proximal tubule segments in mice: response to type 1 diabetes, SGLT1/2 inhibition, or GLP1 receptor agonismAmerican journal of physiology. Renal physiology · 2025
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE279174_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1171019 and SRA study SRP537635. Searching any of these in the dataset finder brings you back here.
The grouping that defines any comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Sample titles run LCM54 … LCM74 and carry no group information.
- GSM8563593 LCM54
- GSM8563594 LCM58
- GSM8563595 LCM67
- GSM8563596 LCM75
- GSM8563597 LCM83
- GSM8563598 LCM84
- GSM8563599 LCM2
- GSM8563600 LCM42
- GSM8563601 LCM64
- GSM8563602 LCM87
- GSM8563603 LCM94
- GSM8563604 LCM95
- GSM8563605 LCM10
- GSM8563606 LCM11
- GSM8563607 LCM18
- GSM8563608 LCM44
- GSM8563609 LCM55
- GSM8563610 LCM72
- GSM8563611 LCM61
- GSM8563612 LCM65
- GSM8563613 LCM9
- GSM8563614 LCM96
- GSM8563615 LCM97
- GSM8563616 LCM98
- GSM8563617 LCM1
- GSM8563618 LCM30
- GSM8563619 LCM40
- GSM8563620 LCM76
- GSM8563621 LCM8
- GSM8563622 LCM82
- GSM8563623 LCM15
- GSM8563624 LCM51
- GSM8563625 LCM57
- GSM8563626 LCM69
- GSM8563627 LCM7
- GSM8563628 LCM86
- GSM8563629 LCM85
- GSM8563630 LCM88
- GSM8563631 LCM90
- GSM8563632 LCM91
+ 14 more — browse all 54 samples with per-sample file links →
- GSE325466 Transcriptomics of S3 segment in mice: response to type 1 diabetes, SGLT1/2 inhibition, or GLP1 receptor agonism response to type 1 diabetes, SGLT1/2 inhibition or GLP1 receptor agonism 54 samples shares sglt1, glp1, inhibition, diabetes, receptor
- GSE307181 Sex specific correction of maternal inflammation-induced behavioral abnormalities by the inhibition of colony-stimulating factor 1 receptor 96 samples shares inhibition, receptor
- GSE301765 Deletion of AT1a (Angiotensin II Type 1a) Receptor or Inhibition of Angiotensinogen Synthesis Attenuates Thoracic Aortopathies in Fibrillin1C1041G/+ Mice 26 samples shares inhibition, receptor
- GSE191008 AXL and MERTK receptor tyrosine kinases inhibition protects against pancreatic necrosis via limiting CXCL2-mediated neutrophil infiltration 12 samples shares inhibition, receptor
- GSE327968 Gene expression profiling of GLP1R-IL17A axis in obesity driven PTPN11-mutant leukemia 30 samples shares glp1
- GSE318028 Pharmacological inhibition of FKBP51 mitigates early life adversity-induced social deficits 246 samples shares inhibition
- GSE293819 Monitoring systemic immune responses to checkpoint inhibition in breast cancer reveals host responses and mechanisms of resistance 142 samples shares inhibition
- GSE235623 MERTK inhibition for the treatment of tissue fibrosis [RNA-seq] 86 samples shares inhibition
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.